Shares of Teleflex TFX rose 0.1% in pre-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share decreased 6.73% year over year to $2.77, which beat the estimate of $2.24.
Revenue of $628,301,000 decreased by 3.09% from the same period last year, which beat the estimate of $619,400,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Teleflex hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Oct 29, 2020
Time: 08:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/c5jqihrc
Recent Stock Performance
52-week high: $409.27
52-week low: $221.27
Price action over last quarter: down 10.20%
Company Profile
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (23% of sales), interventional (17%), surgical (14%), anesthesia (13%), interventional urology (11%), original-equipment manufacturing (10%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.